Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Raw Materials: 2022-2024

  • Mainz Biomed N.V's Raw Materials was N/A to $373,718 in Q2 2024 from the same period last year, while for Jun 2024 it was $373,718, marking a year-over-year change of. This contributed to the annual value of $430,004 for FY2023, which is 145.06% up from last year.
  • According to the latest figures from Q2 2024, Mainz Biomed N.V's Raw Materials is $373,718, which was down 13.09% from $430,004 recorded in Q4 2023.
  • In the past 5 years, Mainz Biomed N.V's Raw Materials ranged from a high of $430,004 in Q4 2023 and a low of $175,469 during Q4 2022.
  • In the last 3 years, Mainz Biomed N.V's Raw Materials had a median value of $352,404 in 2023 and averaged $327,570.
  • Data for Mainz Biomed N.V's Raw Materials shows a peak YoY soared of 145.06% (in 2023) over the last 5 years.
  • Over the past 3 years, Mainz Biomed N.V's Raw Materials (Quarterly) stood at $175,469 in 2022, then soared by 145.06% to $430,004 in 2023, then reached $373,718 in 2024.
  • Its last three reported values are $373,718 in Q2 2024, $430,004 for Q4 2023, and $331,090 during Q3 2023.